RecruitingNCT00488878
Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
Data Collection for Patients With Low Grade Ovarian Carcinoma
Sponsor
M.D. Anderson Cancer Center
Enrollment
2,000 participants
Start Date
May 19, 2006
Study Type
OBSERVATIONAL
Conditions
Summary
This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.
Eligibility
Sex: FEMALE
Inclusion Criteria6
- Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis:
- Ovarian tumor of low malignant potential
- Low-grade serous carcinoma of the ovary
- Primary peritoneal tumor of low malignant potential
- Low-grade serous carcinoma of the peritoneum
- Psammocarcinoma
Interventions
PROCEDUREBiospecimen Collection
Patients' residual tissue samples are collected
OTHERElectronic Health Record Review
Medical records are reviewed
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00488878
Related Trials
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589836 locations
Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)
NCT074809541 location
National Cancer Institute "Cancer Moonshot Biobank"
NCT04314401152 locations
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
NCT072821581 location
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
NCT0557936667 locations